Cargando…
STxB as an Antigen Delivery Tool for Mucosal Vaccination
Immunotherapy against cancer and infectious disease holds the promise of high efficacy with minor side effects. Mucosal vaccines to protect against tumors or infections disease agents that affect the upper airways or the lung are still lacking, however. One mucosal vaccine candidate is the B-subunit...
Autores principales: | Tartour, Eric, Johannes, Ludger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948715/ https://www.ncbi.nlm.nih.gov/pubmed/35324699 http://dx.doi.org/10.3390/toxins14030202 |
Ejemplares similares
-
Engineered Synthetic STxB for Enhanced Cytosolic Delivery
por: Hadjerci, Justine, et al.
Publicado: (2023) -
Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
por: Stimmer, Lev, et al.
Publicado: (2014) -
Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice
por: Almasian, Pegah, et al.
Publicado: (2018) -
An in silico Design, Expression and Purification of a Chimeric Protein as an Immunogen Candidate Consisting of IpaD, StxB, and TolC Proteins from Shigella spp.
por: Fathi, Javad, et al.
Publicado: (2022) -
Designing and Analyzing the Structure of DT-STXB Fusion Protein as an Anti-tumor Agent: An in Silico Approach
por: Mohseni Moghadam, Zeynab, et al.
Publicado: (2019)